Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180

Oren Froy

doi:10.2337/dci19-0061

Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180

Oren Froy^*

^*Corresponding author for this work

Institute of Biochemistry, Food Science and Nutrition

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	E13-E14
Journal	Diabetes Care
Volume	43
Issue number	1
DOIs	https://doi.org/10.2337/dci19-0061
State	Published - 1 Jan 2020

Bibliographical note

Funding Information:
Funding. Funding was received from the Israeli Ministry of Health (grant no. 3-00000-12856). Duality of Interest. No potential conflicts of interest relevant to this article were reported.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2337/dci19-0061

Cite this

@article{b0d3dd34587e46399f0aa6f35cd72b05,

title = "Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180",

author = "Oren Froy",

note = "Funding Information: Funding. Funding was received from the Israeli Ministry of Health (grant no. 3-00000-12856). Duality of Interest. No potential conflicts of interest relevant to this article were reported.",

year = "2020",

month = jan,

day = "1",

doi = "10.2337/dci19-0061",

language = "אנגלית",

volume = "43",

pages = "E13--E14",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "1",

}

TY - JOUR

T1 - Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet

T2 - A randomized clinical trial. Diabetes care 2019;42:2171-2180

AU - Froy, Oren

N1 - Funding Information: Funding. Funding was received from the Israeli Ministry of Health (grant no. 3-00000-12856). Duality of Interest. No potential conflicts of interest relevant to this article were reported.

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://www.scopus.com/pages/publications/85077025171

U2 - 10.2337/dci19-0061

DO - 10.2337/dci19-0061

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 31862829

AN - SCOPUS:85077025171

SN - 0149-5992

VL - 43

SP - E13-E14

JO - Diabetes Care

JF - Diabetes Care

IS - 1

ER -

Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this